Experimental pancreatic cancer combo trial halted early
Disease control
Terminated
This early-phase study tested whether adding the experimental drug NIS793 to standard chemotherapy (FOLFIRINOX) could help people with metastatic pancreatic cancer. Only 4 people took part before the study was stopped. The goal was to find a safe dose and see if the combination c…
Phase: PHASE1 • Sponsor: Colin D. Weekes, M.D., PhD • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC